Record Citations
APA (7th ed.) Citation
Lu, W., Sun, J., Jing, Y., Xu, J., Huang, C., Deng, Y., . . . Li, Y. (2025). Combined Use of Gefitinib and Bevacizumab in Advanced Non-Small-Cell Lung Cancer with <i>EGFR</i> G719S/S768I Mutations and Acquired C797S Without T790M After Osimertinib: A Case Report and Literature Review. MDPI AG.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Lu, Wenting, Jiayi Sun, Yawan Jing, Jing Xu, Chengming Huang, Yi Deng, Panwen Tian, and Yalun Li. Combined Use of Gefitinib and Bevacizumab in Advanced Non-Small-Cell Lung Cancer with <i>EGFR</i> G719S/S768I Mutations and Acquired C797S Without T790M After Osimertinib: A Case Report and Literature Review. MDPI AG, 2025.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Lu, Wenting, et al. Combined Use of Gefitinib and Bevacizumab in Advanced Non-Small-Cell Lung Cancer with <i>EGFR</i> G719S/S768I Mutations and Acquired C797S Without T790M After Osimertinib: A Case Report and Literature Review. MDPI AG, 2025.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.